Acta Med. 2003, 46: 131-137

Control of T Cell Responses, Tolerance and Autoimmunity by Regulatory T Cells: Current Concepts

Pavel Chrobák

Institute of Clinical Research of Montreal, Molecular Biology Unit, Montreal, Quebec, Canada

Received August 1, 2003
Accepted September 1, 2003


1. Akbari O, Freeman GJ, Meyer EH et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002; 8:1024–32. <>
2. Almeida AR, Legrand N, Papiernik M, Freitas AA. Homeostasis of peripheral CD4+ T cells: IL-2Rα and IL-2 shape a population of regulatory cells that controls CD4+ T-cell numbers. J Immunol 2002; 169:4850–60. <>
3. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T-cell subpopulation. J Exp Med 1996; 184:387–96. <> <PubMed>
4. Barrat FJ, Cua DJ, Boonstra A et al. In vitro generation of interleukin 10–producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2–inducing cytokines. J Exp Med 2002; 195:603–16. <> <PubMed>
5. Bach JF. Immunotherapy of insulin-dependent diabetes mellitus. Curr Opin Immunol 2001; 13(5):601–5. <>
6. Bach JF. Regulatory T cells unde Scrutiny. Nature Rev Immunol 2003; 3:189–98. <>
7. Barthlott T, Kassiotis G, Stockinger B. T cell regulation as a side effect of homeostasis and competition. J Exp Med 2003; 197(4):451–60. <> <PubMed>
8. Belghith M, Bluestone JA, Barriot S,Megret J, Bach JF, Chatenoud L. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nature Med 2003; 9:1202–8. <>
9. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420:502–7. <>
10. Bensinger SJ, Bandeira A, Jordan MS, Caton AJ, Laufer TM. Major histocompatibility complex class-II-positive cortical epithelium mediates the selection of CD4+CD25+ immunoregulatory T cells. J Exp Med 2001; 194:427–38. <> <PubMed>
11. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nature Rev Immunol 2003; 3:253–7. <>
12. Boitard C, Yasunami R, Dardenne M, Bach JF. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 1989; 169(5):1669–80. <> <PubMed>
13. Bushell A, Morris PJ, Wood KJ. Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response. Eur J Immunol 1995; 25(9): 2643–96. <>
14. Chai JG, Bartok I, Chandler P et al. Anergic T cells act as suppressor cells in vitro and in vivo. Eur J Immunol 1999; 29:686–92. <<686::AID-IMMU686>3.0.CO;2-N>
15. Chaillous L, Lefevre H, Thivolet C et al. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomized controlled trial. Diabete Insuline Orale group. Lancet 2000; 356:545–9. <>
16. Chatenoud L. CD-3 specific antibody-induced active tolerance: from bench to bedside. Nature Rev Immunol 2003; 3:123–32. <>
17. Chen C, Lee WH, Yun P, Snow P, Liu CP. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes. J Immunol 2003; 171(2):733–44. <>
18. Cortez F, Hurst SD, Coffman RL, Groux H. T regulatory cells 1 inhibit a Th2–specific response in vivo. J Immunol 2000; 165:4848–53.
19. Davies JD, Leong LY, Mellor A, Cobbold SP, Waldmann H. T-cell suppression in transplantation tolerance through linked recognition. J Immunol 1996; 156: 3602–7.
20. Dieckmann D, Bruett CH, Ploettner H, Luty MB, Schuler G. Human CD4+ CD25+ regulatory, contact-dependent T cells induce interleukin-10–producing, contact-independent type-1–like regulatory T cells. J Exp Med 2002; 196:247–53. <> <PubMed>
21. Faria AM, Weiner HL. Oral tolerance: mechanisms and therapeutic applications. Adv Immunol 1999; 73:153–264. <>
22. Fowell D, Mason D. Evidence that the T-cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization CD4+ T-cell subset that inhibits this autoimmune potential. J Exp Med 1993; 177:627–36. <> <PubMed>
23. Garren H, Ruiz PJ,Watkins TA et al. Combination of gene delivery and D N A vaccination to protect from and reverse TH1 autoimmune disease via deviation to the TH2 pathway. Immunity 2001; 15:15–22. <>
24. Gavin MA, Clarke SR, Negrou A, Gallegos A, Rudensky A. Homeostasis and anergy of CD4+ CD25+ suppressor T cells in vivo. Nat Immunol 2002; 3:33–41. <>
25. Gershon RK, Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 1970; 18:723–37.
26. Gonzales A, Andre-Schmutz I, Camaud C, Mathis D, Benoist C. Damage control, rather than unresponsivenss, effected by protective DX5+ T cells in autoimmune diabetes. Nat Immunol 2001; 2:1117–25. <>
27. Groux H. Type 1 T-regulatory cells: their role in the control of immune responses. Transplantation 2003; 75(Suppl. 9):8S-12S. <>
28. Groux H, O’Garra A, Bigler M et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389:737–42. <>
29. Hanninen A, Martinez NR, Davey GM, Heath WR, Harrison LC. Transient blockade of CD40 ligand dissociates pathogenic from protective mucosal immunity. J Clin Invest 2002; 109:261–7. <>
30. Herold KC, Hagopian W, Auger JA et al. Anti-CD3 monoclonal antibody in newonset type 1 diabetes mellitus. N Engl J Med 2002; 346:1692–8. <>
31. Homan D, Holtz A, Bot A et al. Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity 1999:11(4):463–72. <>
32. Iwashiro M, Messer RJ, Peterson KE, Strommes IM, Sugie T, Hasenkrug KJ. Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection. Proc Natl Acad Sci USA 2001; 98:9226–30. <> <PubMed>
33. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10 producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192:1213–22. <> <PubMed>
34. Jooss K, Gjata B, Danos O, von Boehmer H, Sarukhan A. Regulatory function of in vivo anergized CD4+ T cells. Proc Natl Acad Sci USA. 2001; 98:8738–43. <> <PubMed>
35. Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421(6921):388–92. <>
36. Lee S, Scherberg N, DeGroot LJ. Induction of oral tolerance in human autoimmune thyroid disease. Thyroid 1998; 8:229–34. <>
37. Lepault F, Gagnerault MC. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J Immunol 2000; 164(1): 240–7. <>
38. Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T cells. Nat Immunol 2003; 4:350–4. <>
39. Lombardi G, Sidhu S, Batchelor R, Lechler R. Anergic T cells as suppressor cells in-vitro. Science 1994; 264:1587–9. <>
40. Madakamutil LT, Maricic I, Sercary E, Kumar V. Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes. J Immunol 2003; 170(6):2985–92. <>
41. Malek TR, Yu A, Vincek V, Scibelli P, Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ−deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002; 17:167–78. <>
42. Marshall NA, Vickers MA, Barker RN. Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1. J Immunol 2003; 170:6183–9. <>
43. Metzler B, Wraith DC. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol 1993; 5:1159–65. <>
44. McGuirk P, McCann C, Mills KH. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 2002; 195:221–31. <> <PubMed>
45. McGuirk P, Mills KH. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectiozus diseases. Trends Immunol 2002; 23(9):450–5. <>
46. Nishizuka Y, Sakakura T. Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 1969; 166:753–5. <>
47. Poudrier J, Weng X, Kay DG, Hanna Z, Jolicoeur P. The AIDS-like disease of CD4C/HIV Tg mice is associated with accumulation of immature CD11bHi dendritic cells. J Virol (In Press).
48. Ramsdell F. Foxp3 and Natural Regulatory T Cells: Key to a Cell Lineage? Immunity 2003; 19:165–8. <>
49. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains. J Immunol 1995; 155:1151–64.
50. Schwartz RH. T Cell Anergy. Ann Rev Immunol 2003; 21:305–34. <>
51. Shanmugam A, Copie-Bergman C, Hashim G et al. Healthy monozygous twins do not recognize identical T-cell epitopes on the myelin basic protein autoantigen. Eur J Immunol 1994; 24:2299–303. <>
52. Seddon B, Mason D. Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor -β and interleukin-4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4+CD45RC-cells and CD4+CD8–thymocytes. J Exp Med 1999; 189:279–88. <> <PubMed>
53. Singh B, Read S, Asseman C et al. Control of intestinal inflammation by regulatory T cells. Immunol Review 2001; 182:190–200. <>
54. Stephens GL, Ignatowicz L. Decreasing the threshold for thymocyte activation biases CD4+ T cells toward a regulatory (CD4+ CD25+) lineage. Eur J Immunol 2003; 33(5):1282–92. <>
55. Tanchot C, Barber DL, Chiodetti L, Schwartz RH. Adaptive tolerance of CD4+ T cells in vivo: multiple thresholds in response to a constant level of antigen presentation. J Immunol 2001; 167:2030–9. <>
56. Teshima T, Reddy P, Liu C, Williams D, Cooke KR, Ferrara JLM. Impaired thymic negative selection causes autoimmune graft- versus-host disease. Blood 2003; 102:429–35. <>
57. Thornton AM, Shevach EM. CD4+ CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188:287–96. <> <PubMed>
58. Thorstenson KM, Khoruts A. Generation of anergic and potentially immunoregulatory CD25+ CD4+ T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001; 167:188–95. <>
59. Thurau SR, Diedrichs-Mohring M, Fricke H, Arbogast S, Wildner G. Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis patients with an MHC-peptide crossreactive with autoantigen-first results. Immunol Lett 1997; 57:193–201. <>
60. Trentham DE, Dynesius-Trentham RA, Orav EJ et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993; 261(5129): 1727–30. <>
61. Viney Jl, Mowat AM, O’Malley JM, Williamson E, Fanger NA. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J Immunol 1998; 160(12):5815–25.
62. vonHerrath MG, Harrison LC. Antigen-induced regulatory T cells in autoimmunity. Nature Rev Immunol 2003; 3:223–32. <>
63. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cortez F, Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003; 18:605–17. <>
64. Weiner HL. Induction and mechanism of action of transforming growth factorbeta- secreting Th3 regulatory cells. Immunol Rev 2001; 182:207–14. <>
65. Weiner HL. The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nat Immunol 2001; 2(8):671–2. <>
66. Weiner HL, Friedman A, Miller A et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994; 12:809–37. <>
67. Weiner HL, Mackin GA, Matsui M et al. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993; 259(5099):1321–4. <>
68. Yamazaki S, Iyoda T, Tarbell K et al. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 2003; 198(2):235–47. <> <PubMed>
69. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 1991; 88(22):10252–6. <> <PubMed>
70. Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25–precursors. J Immunol 2002; 169(8):4183–9. <>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal